wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48317730-EC4D0863-3C8B-4FC9-90ED-18A75917DE04
Q48317730-EC4D0863-3C8B-4FC9-90ED-18A75917DE04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48317730-EC4D0863-3C8B-4FC9-90ED-18A75917DE04
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [(14)C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.
P2860
Q48317730-EC4D0863-3C8B-4FC9-90ED-18A75917DE04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48317730-EC4D0863-3C8B-4FC9-90ED-18A75917DE04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fdb67c79a1c97a80d972cc91ed67061a592cd9a8
P2860
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.